BlackRock holds 14.3% of Chemours (NYSE: CC) — 21.48M shares reported
Rhea-AI Filing Summary
BlackRock, Inc. amended a Schedule 13G/A to report beneficial ownership of 21,484,477 shares of Chemours Company common stock, representing 14.3% of the class. The filing shows sole voting power for 21,244,817 shares and sole dispositive power for 21,484,477 shares. The filing notes that iShares Core S&P Small-Cap ETF has an interest exceeding 5% in Chemours common stock. The amendment is signed by Spencer Fleming, Managing Director, dated 04/24/2026.
Positive
- None.
Negative
- None.
Insights
BlackRock reports a 14.3% stake in Chemours, with primary voting and dispositive control.
BlackRock's Schedule 13G/A amendment lists 21,484,477 shares beneficially owned and records 21,244,817 shares as sole voting power. This indicates consolidated reporting by BlackRock's Reporting Business Units under SEC guidance.
Large passive positions like this reflect institutional exposure rather than an active takeover intent; subsequent filings (e.g., ownership changes or Form 13D) would show any change in intent or activism. Future ownership updates will appear in amended schedules if BlackRock's holdings or voting arrangements change.